Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock

Journal of Critical Care

Volumn 27, Issue 6, 2012, Pages 616-622

  Tamayo, Eduardo ^a   Fernández, Ana ^a   Almansa, Raquel ^a   Carrasco, Elena ^a   Goncalves, Lisbeth ^a   Heredia, María ^a   Andaluz Ojeda, David ^a   March, Gabriel ^a   Rico, Lucia ^a   Gómez Herreras, Jose I ^a   de Lejarazu, Raúl Ortiz ^a   Bermejo Martin, Jesus F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Endogenous; Immunoglobulin; Isotype; Sepsis; Subclass

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; LACTIC ACID; PROCALCITONIN;

AGED; APACHE; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROTEIN FUNCTION; SEPTIC SHOCK; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84870658458     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.08.004     Document Type: Article

References (18)

1. Venet F., Gebeile R., Bancel J., et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol 2011, 11:2086-2090.
2. Andaluz-Ojeda D., Iglesias V., Bobillo F., et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011, 15:R243.
3. Taccone F.S., Stordeur P., De Backer D., et al. Gamma-globulin levels in patients with community-acquired septic shock. Shock 2009, 32:379-385.
4. Laupland K.B., Kirkpatrick A.W., Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 2007, 35:2686-2692.
5. Werdan K., Pilz G., Bujdoso O., et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 2007, 35:2693-2701.
6. Kreymann K.G., de Heer G., Nierhaus A., et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007, 35:2677-2685.
7. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009, 136:e28.
8. Lennette E.H.H.W., Shadomy H.J. Manual of clinical microbiology 1985, 160-200. American Society for Microbiology, Washington, DC.
9. Ferreira F.L., Bota D.P., Bross A., et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286(14):1754-1758.
10. Schroeder H.W., Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010, 125:S41-S52.
11. Rose ME, Lang DM: Evaluating and managing hypogammaglobulinemia. Cleve Clin J Med 73:133-137, 140, 143-134, 2006.
12. Pan Q., Hammarstrom L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000, 178:99-110.
13. Blaese RM WJ: IgG subclass deficiency and specific antibody deficiency. Patient & Family Handbook for Primary Immunodeficiency Diseases Immune Deficiency Foundation In Towson MD, ed 51-53, 2007.
14. Driessen G., van der Burg M. Educational paper: primary antibody deficiencies. Eur J Pediatr 2011, 170:693-702.
15. Coutinho H.B., Robalinho T.I., Coutinho V.B., et al. Intra-abdominal sepsis: an immunocytochemical study of the small intestine mucosa. J Clin Pathol 1997, 50:294-298.
16. Monneret G., Venet F., Kullberg B.J., et al. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 2010, 49(Suppl. 1):S17-S23.
17. Monneret G., Venet F., Pachot A., et al. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78.
18. Soares M.O., Welton N.J., Harrison D.A., et al. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 2012, 16:1-186.